Recommended content

FDA warning about injectable cannabis products (Newsletter: March 17, 2025)

GOP congressman: Trump could boost psychedelics reform; PA medical marijuana patient DUI bill; Study: Cannabis effective for PTSD

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Your support makes Marijuana Moment possible…

Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there.

Support our work at https://www.patreon.com/marijuanamoment

/ TOP THINGS TO KNOW

Rep. Jack Bergman (R-MI) argued in an interview with Marijuana Moment that the Trump administration’s efforts to cut government spending and the federal workforce will help advance psychedelics reform by giving agencies “spines” to tackle such complex issues.

The Food and Drug Administration sent a warning letter to a cannabis company about its “especially concerning” injectable CBD product, alleging it has made unsanctioned claims about its potential health benefits.

A Pennsylvania representative filed a bill to protect medical cannabis patients from being charged with driving under the influence when they are not actually impaired behind the wheel.

A new

Read full article on Marijuana Moment

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Moment
Source

More news